There were 1,855 press releases posted in the last 24 hours and 358,806 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
TG Therapeutics Announces Orphan Drug Designation for the Combination of TG-1101 and TGR-1202 for Treatment of Chronic Lymphocytic Leukemia

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image